Controversial issues on melanoma

Dermatologic Therapy

Volumn 25, Issue 5, 2012, Pages 458-462

  Lotti, Torello ^a   Bruscino, Nicola ^a   Hercogova, Jana ^b   De Giorgi, Vincenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

Author keywords

melanoma; sentinel lymph node biopsy; sun exposure; UV ray (UVR)

Indexed keywords

DNA; MELANIN; REACTIVE OXYGEN METABOLITE; VITAMIN D RECEPTOR;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CONTROL; CANCER SURVIVAL; DAILY LIFE ACTIVITY; DNA DAMAGE; HUMAN; KERATINOCYTE; LYMPH NODE DISSECTION; MELANOCYTE; MELANOMA; MELANOMA METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RADIATION EXPOSURE; RADIATION MUTAGENESIS; SENTINEL LYMPH NODE BIOPSY; SUN EXPOSURE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION;

HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MELANOMA; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SUNLIGHT; SURVIVAL RATE; ULTRAVIOLET RAYS;

EID: 84867369751     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2012.01524.x     Document Type: Article

References (32)

1. Solomon CC, White E, Kristal AR, Vaughan T,. Melanoma and lifetime UV radiation. Cancer Causes Control 2004: 15: 893-902.
2. Narayanan DL, Saladi RN, Fox JL,. Ultraviolet radiation and skin cancer. Int J Dermatol 2010: 49: 978-986.
3. De Giorgi V, Gori A, Grazzini M, et al. Sun exposure and children: what do they know? An observational study in an Italian school. Prev Med 2011: 52: 186-187.
4. Walker G,. Cutaneous melanoma: how does ultraviolet light contribute to melanocyte transformation? Future Oncol 2008: 4: 841-856.
5. Maddodi N, Setaluri V,. Role of UV in cutaneous melanoma. Photochem Photobiol 2008: 84: 528-536.
6. Abdel-Malek ZA, Kadekaro AL, Swope VB,. Stepping up melanocytes to the challenge of UV exposure. Pigment Cell Melanoma Res 2010: 23: 171-186.
7. Ivry GB, Ogle CA, Shim EK,. Role of sun exposure in melanoma. Dermatol Surg 2006: 32: 481-492.
8. Moan J, Porojnicu AC, Dahlback A, Grant WB, Juzeniene A,. Where the sun does not shine: is sunshine protective against melanoma of the vulva? J Photochem Photobiol B 2010: 101: 179-183.
9. Rigel DS,. Cutaneous ultraviolet exposure and its relationship to the development of skin cancer. J Am Acad Dermatol 2008: 58: s129-s132.
10. Ross MI,. Sentinel node biopsy for melanoma: an update after two decades of experience. Semin Cutan Med Surg 2010: 29: 238-248.
11. Cabanas R,. An approach for the treatment of penile carcinoma. Cancer 1977: 39: 456-466.
12. Morton D, Wen D, Wong J, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992: 127: 392-399.
13. Leong SPL, Zuber M, Ferris RL, et al. Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients. J Surg Oncol 2011: 103: 518-530.
14. Leiter U, Buettner PG, Bohnenberger K, et al. Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement. Ann Surg Oncol 2010: 17: 129-137.
15. Prieto VG,. Sentinel lymph nodes in cutaneous melanoma. Arch Pathol Lab Med 2010: 134: 1764-1769.
16. Gershenwald JE, Ross MI,. Sentinel-lymph-node biopsy for cutaneous melanoma. N Engl J Med 2011: 364: 1738-1745.
17. Lens M,. Sentinel lymph node biopsy in melanoma patients. J Eur Acad Dermatol Venereol 2010: 24: 1005-1012.
18. Sekula-Gibbs SA, Shearer MA,. Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one. Dermatol Surg 2011: 37: 1080-1088.
19. Roach BA, Burton AL, Mays MP, et al. Does mitotic rate predict sentinel lymph node metastasis or survival in patients with intermediate and thick melanoma? Am J Surg 2010: 200: 759-764.
20. Thompson JF, Shaw HM,. Should tumor mitotic rate and patient age, as well as tumor thickness, be used to select melanoma patients for sentinel node biopsy? Ann Surg Oncol 2004: 11: 233-235.
21. De Giorgi V, Grazzini M, Papi F, Gori A, Rossari S, Lotti T,. Sentinel lymph node biopsy: is it an evolution of the management of cutaneous melanoma? Ann Surg Oncol 2011: 18: 598-599.
22. De Giorgi V, Grazzini M, Massi D,. Sentinel-lymph-node biopsy for cutaneous melanoma. N Engl J Med 2011: 365: 570-571.
23. Thomas JM,. Caution with sentinel node biopsy in melanoma. Br J Surg 2006: 93: 129-130.
24. Thomas JM,. Time to re-evaluate sentinel node biopsy in melanoma postmulticenter selective lymphadenectomy trial. J Clin Oncol 2005: 23: 9443-9444.
25. Morton DL, Cochran AJ, Thompson JF, et al. Lymphadenectomy trial group. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-1, an international multicenter trial. Ann Surg 2005: 242: 302-311.
26. Amersi F, Morton DL,. The role of sentinel lymph node biopsy in the management of melanoma. Adv Surg 2007: 41: 241-256.
27. De Giorgi V, Leporatti G, Massi D, et al. Sentinel lymph nodes in melanoma patients: evaluating the evidence. Oncology 2006: 71: 460-462.
28. De Giorgi V, Leporatti G, Massi D, et al. Outcome of patients with melanoma and histologically negative sentinel lymph nodes: one institution's experience. Oncology 2007: 73: 401-406.
29. Van Akkooi ACJ, Voit CA, Verhoef C, Eggermont AM,. New developments in sentinel node staging in melanoma: controversies and alternatives. Curr Opin Oncol 2010: 22: 169-177.
30. De Giorgi V, Gori A, Grazzini M, et al. Contrast-enhanced ultrasound: a filter role in AJCC stage I/II melanoma patients. Oncology 2010: 79: 370-375.
31. Estourgie SH, Nieweg OE, Kroon BBR,. High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma. Br J Surg 2004: 91: 1370-1371.
32. Thomas JM, Clark MA,. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma. Eur J Surg Oncol 2004: 30: 686-691.